Medical Foods Market is expected to grow at a CAGR of 6.3% from 2023 to 2032

Market Research Future (MRFR) has published a cooked research report on the “global medical foods market” that contains information from 2019 to 2032. the medical foods market is estimated to register a CAGR of 6.27% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the global medical foods market— Danone SA (France), Abbott (US), Fresenius Kabi AG (Germany), TARGETED MEDICAL PHARMA INC (US), Metagenics LLC (US), Nestlé (Switzerland), Reckitt Benckiser Group PLC (UK), Medtrition, Inc (US), Primus Pharmaceuticals, inc (US), and Alfasigma USA, Inc (US).

Medical Foods Market Highlights

The global medical foods market is accounted to register a CAGR of 6.3% during the forecast period and is estimated to reach USD 35.3 billion by 2032.

Manufacturers' increasing product launch activities and continuous innovations in product development are expected to drive product demand. For instance, in October 2020, Nestle Health Science (Switzerland), introduced protein-based ready-to-drink nutritional food in China for special medical purposes. (FSMPs). The drink's primary ingredient is a galactomannan, a highly soluble dietary fiber that can help prevent gastrointestinal intolerance and diarrhea. Therefore, increasing product launch initiatives and constant innovations in developing products will create lucrative opportunities for the players operating in the global medical foods market.

The increasing prevalence of chronic diseases, growing nutritional deficiency among people, and raising awareness about prebiotics and probiotic products are propelling the market growth. However, a lack of awareness regarding medical food is expected to hamper the growth of the global market. Nevertheless, the increasing product launch initiatives and constant innovations in developing products are projected to create lucrative opportunities for market players.

Segment Analysis

The global medical foods market has been segmented based on nutritional ingredients, route of administration, form, application, and distribution channel.

On the basis of nutritional ingredients, the market is segmented into vitamins and minerals, proteins, omega-3, isoflavones, phytosterols, and others. The proteins segment was attributed to holding the largest market share in 2022 with a market share of 28.33% revenue as estimated by MRFR analysts. This is due to rising public awareness of children’s nutrition, rising protein functionalities, and awareness about protein-rich diets. Moreover, proteins are required for the body's proper functioning. Furthermore, they serve as the foundation for body structures like skin and hair, as well as other substances like enzymes, cytokines, and antibodies.

Further, we estimate that the market segment would continue to pool in the largest chunk of revenue during the forecast period. It has been identified that the segment market yet witnesses continuous innovations and movements in terms of new product launches

On the basis of the route of administration, the market is segmented into oral and enteral. The oral segment was attributed to holding the largest market share in 2022.

On the basis of form, the market is segmented into pills, powder, and others. The powder segment was attributed to holding the largest market share in 2022.

On the basis of application, the market is segmented into chronic kidney disease, nutritional deficiency, neurological & psychological disorders, metabolic disorders, pain management, gastrointestinal disorders, orphan diseases, and others. The nutritional deficiency segment was attributed to holding the largest market share in 2022.

On the basis of the distribution channel, the market is segmented into e-commerce, hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment is projected to have the largest market share during the forecast period.

Regional Analysis

The global medical foods market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America consists of US and Canada. The Europe medical foods market comprises Germany, France, the UK, Italy, Spain, and the rest of Europe. The medical foods market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the world’s medical foods market comprises of Middle East, Africa, and Latin America.

The increasing prevalence of chronic diseases such as diabetes, cancer, cardiovascular disorders, and others, the rise in the adoption of medical foods in the region, and the rising strategic partnership and increasing investment by major players, are boosting the growth of the North American region. In addition, the well-established healthcare infrastructure and rising demand for personalized nutrition also contribute to the growth of the North American medical foods market.

Moreover, the Europe market has been persistently growing owing to increasing awareness of the benefits of medical foods, the growing development of new formulations, such as plant-based proteins & probiotics, and the rising aging population in the European Medical Foods Market.

Additionally, market factors, such as improving healthcare infrastructure, rising geriatric population & diseases associated with old age, and growing health awareness among the population in the Asia-Pacific region and are driving the region’s growth.

Furthermore, the rest of the world's medical foods market is divided into the Middle East, Africa, and Latin America. The major factors driving the growth of the medical foods market in the region are improving healthcare facilities, the growing availability of medical food products, and the increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders in these regions. Furthermore, an increase in sedentary lifestyles, urbanization, and changes in dietary habits has led to a growing demand for medical foods to manage chronic diseases and improve overall health is expected to propel the medical foods market growth in the region.

Key Findings of the Study

• The global medical foods market is expected to reach USD 35.3 billion by 2032, at a CAGR of 6.3% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market, owing to the improving healthcare infrastructure, rising geriatric population & diseases associated with old age, and growing health awareness among the population in the Asia-Pacific region.


• Based on application, the nutritional deficiency segment was attributed to holding the largest market in 2022, with an approximate market share of 20%.


• Danone SA (France), Abbott (US), Fresenius Kabi AG (Germany), TARGETED MEDICAL PHARMA INC (US), Metagenics LLC (US), Nestlé (Switzerland), Reckitt Benckiser Group PLC (UK), Medtrition, Inc (US), Primus Pharmaceuticals, inc (US), and Alfasigma USA, Inc (US) are the key market players.